These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 1907361)

  • 1. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes.
    Bannister AJ; Cook A; Kouzarides T
    Oncogene; 1991 Jul; 6(7):1243-50. PubMed ID: 1907361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper.
    Kouzarides T; Packham G; Cook A; Farrell PJ
    Oncogene; 1991 Feb; 6(2):195-204. PubMed ID: 1847997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ubiquitous nuclear protein stimulates the DNA-binding activity of fos and jun indirectly.
    Abate C; Luk D; Curran T
    Cell Growth Differ; 1990 Oct; 1(10):455-62. PubMed ID: 2126189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
    Cohen DR; Curran T
    Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
    Hirai S; Yaniv M
    New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing fos oncoprotein to a jun-independent DNA binding protein with GCN4 dimerization specificity by swapping "leucine zippers".
    Sellers JW; Struhl K
    Nature; 1989 Sep; 341(6237):74-6. PubMed ID: 2505087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folding transition in the DNA-binding domain of GCN4 on specific binding to DNA.
    Weiss MA; Ellenberger T; Wobbe CR; Lee JP; Harrison SC; Struhl K
    Nature; 1990 Oct; 347(6293):575-8. PubMed ID: 2145515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucine zippers of fos, jun and GCN4 dictate dimerization specificity and thereby control DNA binding.
    Kouzarides T; Ziff E
    Nature; 1989 Aug; 340(6234):568-71. PubMed ID: 2505081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-binding specificity of PAR and C/EBP leucine zipper proteins: a single amino acid substitution in the C/EBP DNA-binding domain confers PAR-like specificity to C/EBP.
    Falvey E; Marcacci L; Schibler U
    Biol Chem; 1996 Dec; 377(12):797-809. PubMed ID: 8997490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Fos protein containing the Jun leucine zipper forms a homodimer which binds to the AP1 binding site.
    Neuberg M; Adamkiewicz J; Hunter JB; Müller R
    Nature; 1989 Sep; 341(6239):243-5. PubMed ID: 2506451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
    Kerppola TK; Curran T
    Oncogene; 1994 Mar; 9(3):675-84. PubMed ID: 8108109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered protein conformation on DNA binding by Fos and Jun.
    Patel L; Abate C; Curran T
    Nature; 1990 Oct; 347(6293):572-5. PubMed ID: 2120592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the leucine zipper in the fos-jun interaction.
    Kouzarides T; Ziff E
    Nature; 1988 Dec; 336(6200):646-51. PubMed ID: 2974122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos.
    Nikitovic D; Holmgren A; Spyrou G
    Biochem Biophys Res Commun; 1998 Jan; 242(1):109-12. PubMed ID: 9439619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of a dominant-negative mutant of c-Jun.
    Brown PH; Chen TK; Birrer MJ
    Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulation of c-fos: too much is never enough.
    Curran T; Abate C; Baker S; Kerppola T; Xanthoudakis S
    Adv Second Messenger Phosphoprotein Res; 1993; 28():271-7. PubMed ID: 8398414
    [No Abstract]   [Full Text] [Related]  

  • 18. Fos, Jun and CREB basic-domain peptides have intrinsic DNA-binding activity enhanced by a novel stabilizing factor.
    Busch SJ; Sassone-Corsi P
    Oncogene; 1990 Oct; 5(10):1549-56. PubMed ID: 2147467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. fos-jun Conspiracy: implications for the cell.
    Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
    Princess Takamatsu Symp; 1989; 20():119-26. PubMed ID: 2518685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of positively charged tripeptide to N-terminus of the Fos basic region leucine zipper domain: implications on DNA bending, affinity, and specificity.
    Mahmoudi T; Sarkar B
    Biopolymers; 1999 Sep; 50(3):273-86. PubMed ID: 10397789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.